Reevaluation of the histomorphology and a recent application of immunohistochemistry have not only confirmed a pancreatic endocrine insulin producing tumor, but also enabled reclassification of the tumor into pancreatic insulinoma of uncertain malignant potential according to the criteria suggested by Solcia et al. [9]. This evidence concerns the gene INS and pancreatic insulinoma.